| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10918253 | Radiotherapy and Oncology | 2014 | 4 Pages |
Abstract
Dosimetric intra-fraction uncertainties in MRI-guided brachytherapy were analysed for HR-CTV and OARs. While dose differences were generally small, individual outliers occurred. In contrast to HDR, patients treated with PDR show increased mean rectal dose over time. Re-imaging prior to dose delivery helps to detect unfavorable anatomical changes, and allows for intervention.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Christel N. Nomden, Astrid A.C. de Leeuw, Judith M. Roesink, Robbert J.H.A. Tersteeg, Henrike Westerveld, Ina M. Jürgenliemk-Schulz,